Kyverna Therapeutics, Inc. shares surged on strong Phase 2 KYSA-8 data for Miv-cel in stiff person syndrome. Read why KYTX ...
As clinical research evolves, disruptive trial designs are reshaping how oncology advances. By integrating novel ...
Orca-T immunotherapy shows promising results in improving survival and reducing complications in patients with hematologic ...
Kraig Biocraft Laboratories set a distinctive tone with a detailed Christmas shareholder letter that framed 2025 as the company’s inflection year, marking its transition from prolonged development ...
I focus on three high-yield stocks offering attractive risk/reward for income-focused investors. Read the full analysis here.
We may learn more about Jeffrey Epstein's dealings with Les Wexner, the 88-year-old billionaire whose money and influence ...
Teleflex’s TFX Interventional Urology portfolio is well positioned for sustained growth, led by UroLift’s expanding global ...
The Queensland Summer Carnival is getting stronger every weekend and Saturday's Eagle Farm card should be a strong form ...
We may learn more about Jeffrey Epstein's dealings with Les Wexner, the 88-year-old Ohio billionaire whose money and ...
Paulick Report on MSN
Another Fatal Quarter Horse Injury In Premier Race; Los Alamitos Moving To Exclude 'Prominent Owner'
Los Alamitos has made multiple policy changes to address a cluster of racing Quarter Horse fatalities, but more changes are ...
Results from the Precision-T study showed Orca-T significantly improved survival free from chronic GvHD in patients with AML, ALL and MDS compared to a conventional allogeneic hematopoietic stem cell ...
Results from the Precision-T study showed Orca-T significantly improved survival free from chronic GvHD in patients with AML, ALL and MDS compared to a conventional allogeneic hematopoietic stem cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback